HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European trade

This article was originally published in The Rose Sheet

Executive Summary

World Trade Organization final ruling deciding whether U.S. repeal of Foreign Sales Corporation tax provision violates WTO trade regulations and provides unfair subsidy for U.S. businesses will be made public in August, U.S. Trade Representative says. An interim report, issued June 22, will be reviewed by U.S. and European Union. If violation is found, EU will be authorized to issue 100% duties on up to $4 bil. worth of U.S. exports to EU, including cosmetics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009446

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel